One of the best ways to track a conference’s tone is to take to the Twitters. At this week’s Cleveland Clinic Medical Innovation Summit, there was much to be said:
“The days of us claiming value and not being able to deliver on that are numbered – Myriad’s Mark Capone on genetic testing #MIS2014
— Medical Device Daily (@MedDevicesDaily) October 28, 2014
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
.@ClevelandClinic‘s CIO C. Martin Harris: Cleveland Clinic has 300 core systems that have to be coordinated. #MIS2014 #interoperability
— Erin McCann (@EMcCannHITN) October 28, 2014
45 pitches, 59 seconds a piece. Like a delicious popcorn bucket full of buttered and brilliant medical startups. #MIS2014
— mollypopp (@mollypopp) October 28, 2014
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Bundled payments may help drive innovative therapy or delivery. No financial incentive for shorter course of radiation. Khuntia at #MIS2014
— Dale Shepard MD, PhD (@ShepardDale) October 28, 2014
Developing genomic profiles early in cancer treatment will likely be beneficial in a bundled pay system. Dr. Vincent Miller at #MIS2014
— Dale Shepard MD, PhD (@ShepardDale) October 28, 2014
